Risa Takayanagi

453 total citations
57 papers, 362 citations indexed

About

Risa Takayanagi is a scholar working on Pharmacology, Surgery and Genetics. According to data from OpenAlex, Risa Takayanagi has authored 57 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 9 papers in Surgery and 8 papers in Genetics. Recurrent topics in Risa Takayanagi's work include Pharmacy and Medical Practices (15 papers), Inflammatory Bowel Disease (7 papers) and Nausea and vomiting management (5 papers). Risa Takayanagi is often cited by papers focused on Pharmacy and Medical Practices (15 papers), Inflammatory Bowel Disease (7 papers) and Nausea and vomiting management (5 papers). Risa Takayanagi collaborates with scholars based in Japan, United States and Spain. Risa Takayanagi's co-authors include Yasuhiko Yamada, Haruko Yokoyama, Koji Kimura, Tatsuji Iga, Takeshi Ozeki, Yasufumi Sawada, Motohiro Matoba, Kazuo Yago, Kiyomi Ito and Yoko Furuya and has published in prestigious journals such as Journal of Biological Chemistry, Mutation research. Fundamental and molecular mechanisms of mutagenesis and Clinical & Experimental Allergy.

In The Last Decade

Risa Takayanagi

53 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Risa Takayanagi Japan 12 58 52 51 48 46 57 362
Feixiang Wu China 12 75 1.3× 66 1.3× 27 0.5× 13 0.3× 91 2.0× 30 337
Domenico Merante United States 13 63 1.1× 131 2.5× 12 0.2× 20 0.4× 188 4.1× 28 520
Yuan Chi China 12 55 0.9× 141 2.7× 16 0.3× 23 0.5× 21 0.5× 40 432
Hsin‐Ying Lu Taiwan 12 84 1.4× 66 1.3× 54 1.1× 8 0.2× 74 1.6× 27 575
Enikő Sárváry Hungary 14 154 2.7× 81 1.6× 91 1.8× 29 0.6× 44 1.0× 62 641
Tun Kuan Yeo Singapore 15 42 0.7× 83 1.6× 101 2.0× 19 0.4× 41 0.9× 33 629
F Montrone Italy 12 233 4.0× 23 0.4× 45 0.9× 14 0.3× 47 1.0× 33 539
Natalie Houwing United Kingdom 8 130 2.2× 71 1.4× 12 0.2× 30 0.6× 20 0.4× 11 550
L. Buéno France 12 54 0.9× 168 3.2× 13 0.3× 7 0.1× 69 1.5× 15 438
Karin Tunblad Sweden 13 25 0.4× 100 1.9× 55 1.1× 7 0.1× 89 1.9× 21 502

Countries citing papers authored by Risa Takayanagi

Since Specialization
Citations

This map shows the geographic impact of Risa Takayanagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Risa Takayanagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Risa Takayanagi more than expected).

Fields of papers citing papers by Risa Takayanagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Risa Takayanagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Risa Takayanagi. The network helps show where Risa Takayanagi may publish in the future.

Co-authorship network of co-authors of Risa Takayanagi

This figure shows the co-authorship network connecting the top 25 collaborators of Risa Takayanagi. A scholar is included among the top collaborators of Risa Takayanagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Risa Takayanagi. Risa Takayanagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kimura, Koji, Atsushi Yoshida, Fumihiko Katagiri, Risa Takayanagi, & Yasuhiko Yamada. (2020). Prediction of treatment failure during infliximab induction therapy in inflammatory bowel disease patients based on pharmacokinetic and pharmacodynamic modeling. European Journal of Pharmaceutical Sciences. 150. 105317–105317. 5 indexed citations
2.
3.
Takayanagi, Risa, et al.. (2015). Theoretical analysis of headache recurrence in patients administered triptans for migraine based on receptor occupancy. The Journal of Headache and Pain. 16(1). 71–71. 7 indexed citations
4.
Nakamura, Hironori, Haruko Yokoyama, Risa Takayanagi, et al.. (2014). Theoretical evaluation of antiemetic effects of 5-HT3 receptor antagonists for prevention of vomiting induced by cisplatin. European Journal of Drug Metabolism and Pharmacokinetics. 40(1). 39–44. 4 indexed citations
5.
Kimura, Koji, Risa Takayanagi, Haruko Yokoyama, & Yasuhiko Yamada. (2014). Theory-based Analysis of the Anti-inflammatory Effect of TNF Inhibitors on Rheumatoid Arthritis. Drug Metabolism and Pharmacokinetics. 29(3). 272–277. 6 indexed citations
6.
Tani, K., Risa Takayanagi, Haruko Yokoyama, & Yasuhiko Yamada. (2013). Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancy. Rheumatology International. 33(7). 1791–1795. 3 indexed citations
7.
Uotsu, Nobuo, et al.. (2012). Inhibitory effects of kale ingestion on metabolism by cytochrome P450 enzymes in rats. Biomedical Research. 33(4). 235–242. 6 indexed citations
8.
Komatsu, Toshiaki, Ai Suzuki, Risa Takayanagi, et al.. (2012). Population Pharmacokinetics of Oxycodone in Patients With Cancer-Related Pain. Journal of Pain & Palliative Care Pharmacotherapy. 26(3). 220–225. 14 indexed citations
9.
Kimura, Koji, Risa Takayanagi, Haruko Yokoyama, & Yasuhiko Yamada. (2010). Theory-based analysis of anti-inflammatory effect of infliximab on Crohn’s disease and rheumatoid arthritis. Rheumatology International. 32(1). 145–150. 11 indexed citations
10.
Ozeki, Takeshi, Megumi Takeuchi, Motofumi Suzuki, et al.. (2009). Single nucleotide polymorphisms of 17β‐hydroxysteroid dehydrogenase type 7 gene: Mechanism of estramustine‐related adverse reactions?. International Journal of Urology. 16(10). 836–841. 2 indexed citations
11.
Takayanagi, Risa, et al.. (2009). Receptor occupancy theory-based analysis of interindividual differences in antiemetic effects of 5-HT3 receptor antagonists. International Journal of Clinical Oncology. 14(6). 518–524. 10 indexed citations
12.
Kim, Young Jun, Paul S. Murray, Risa Takayanagi, et al.. (2006). Unique Membrane Interaction Mode of Group IIF Phospholipase A2. Journal of Biological Chemistry. 281(43). 32741–32754. 19 indexed citations
13.
Ohno, Yoshiyuki, et al.. (2005). Pharmacokinetic and Pharmacodynamic Analysis of Systemic Effect of Topically Applied Timolol Maleate Ophthalmic Gelling Vehicle (Rysmon® TG). Current Eye Research. 30(4). 319–328. 14 indexed citations
14.
Takayanagi, Risa, et al.. (2002). A Survey of the Attitude of the New Graduate Pharmacists on Clinical Trials.. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 28(5). 489–494. 1 indexed citations
15.
Yamada, Yasuhiko, Yoshiyuki Ohno, Yoshifumi Nakashima, et al.. (2002). Prediction and assessment of extrapyramidal side effects induced by risperidone based on dopamine D2 receptor occupancy. Synapse. 46(1). 32–37. 19 indexed citations
16.
Yamada, Yasuhiko, Risa Takayanagi, Kiyomi Ito, et al.. (2001). Assessment of Systemic Adverse Reactions Induced by Ophthalmic β -Adrenergic Receptor Antagonists. Journal of Ocular Pharmacology and Therapeutics. 17(3). 235–248. 24 indexed citations
17.
18.
Yamada, Yasuhiko, Tetsufumi Inoue, Risa Takayanagi, et al.. (1998). Construction and Assessment of the Consulting System of Adverse Drug Reactions for the Patients.. Japanese Journal of Hospital Pharmacy. 24(3). 243–253. 1 indexed citations
19.
Takayanagi, Risa, Ayana Suzuki, Hideyuki Shimizu, et al.. (1997). Evaluation of the Efficacy of a Prescription Information System for the Rational Use of Medications. Patient Consultations Using a "Drug History Handbook".. Japanese Journal of Hospital Pharmacy. 23(4). 342–347. 3 indexed citations
20.
Aoyama, Takao, Risa Takayanagi, Hideyuki Shimizu, et al.. (1997). Rational Use of Medicine and Its Practice. V; Effects of the Consultation on the Use of Ophthalmic Solutions and an Evaluation of the Consultation Method.. Japanese Journal of Hospital Pharmacy. 23(3). 269–277. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feixiang Wu Breakdown of academic impact, for papers by Domenico Merante Breakdown of academic impact, for papers by Yuan Chi Breakdown of academic impact, for papers by Hsin‐Ying Lu Breakdown of academic impact, for papers by Enikő Sárváry Breakdown of academic impact, for papers by Tun Kuan Yeo Breakdown of academic impact, for papers by F Montrone Breakdown of academic impact, for papers by Natalie Houwing Breakdown of academic impact, for papers by L. Buéno Breakdown of academic impact, for papers by Karin Tunblad
Rankless by CCL
2026